Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aveeno Daily Moisturising Sheer Hydration Lotion is a topical skin protectant and emollient developed by Johnson & Johnson. It is formulated with prebiotic colloidal oatmeal (Avena sativa) and dimethicone to provide 24-hour hydration with a lightweight, breathable feel that absorbs quickly into the skin. The product is primarily indicated for the relief of dry skin and is frequently used as a comparator or adjunctive treatment in clinical studies for atopic dermatitis to evaluate its impact on transepidermal water loss (TEWL) and skin barrier restoration. Unlike the original Aveeno Daily Moisturising Lotion, the Sheer Hydration version is designed to have a non-greasy finish, making it suitable for patients who prefer a lighter texture while maintaining barrier protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aveeno Daily Moisturising Sheer Hydration Lotion.